enGene Therapeutics Inc. Share Price

enGene Therapeutics Inc. Share Price

ENGN
$7.14
-$0.16 (-2.19%) Last updated on 10 Apr, 2026 | 22:28 IST
  • Performance
  • Chart
  • About
  • Price history
  • FAQs

enGene Therapeutics Inc. Stock Performance

Open
$7.26
Prev. Close
$7.30
Circuit Range
N/A
Day Range
$7.11 - $7.26
Year Range
$2.65 - $12.25
Volume
3,092
Average Traded
$7.16

enGene Therapeutics Inc. Share Price Chart

$7.14
Please wait...

About enGene Therapeutics Inc.

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.

enGene Therapeutics Inc. Historical Data

DayOpenCloseChange %
08-Apr-26
$7.13
$7.33
+0.14%
07-Apr-26
$7.30
$7.32
+0.69%
06-Apr-26
$6.90
$7.27
+8.18%
02-Apr-26
$6.64
$6.72
-0.59%
01-Apr-26
$6.96
$6.76
-0.44%
31-Mar-26
$6.79
$6.79
+9.69%
30-Mar-26
$6.44
$6.19
-3.28%

FAQs on enGene Therapeutics Inc. Share Price

Can I buy enGene Therapeutics Inc. shares in India?

chevron-up
Yes. You can buy enGene Therapeutics Inc. in India by opening an international trading account.

What is the share price of enGene Therapeutics Inc.?

chevron-up
As on 10 Apr '26, the share price of enGene Therapeutics Inc. ENGN is $7.14. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.

What is the 5 year returns of enGene Therapeutics Inc.?

chevron-up
The 5 year returns of enGene Therapeutics Inc. is -27.88% as on 10 Apr '26.

What are the high & low stock price of enGene Therapeutics Inc. today?

chevron-up
enGene Therapeutics Inc. stock price hit a high of $7.26 and low of $7.11 as on 10 Apr '26.

What is the 52-week high and low of enGene Therapeutics Inc. stock?

chevron-up
The 52-week high of enGene Therapeutics Inc. stock is $12.25, while the 52-week low is $2.65 as on 10 Apr '26.